Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors and other biologically active compounds. Its boronic acid functionality enables participation in Suzuki-Miyaura cross-coupling reactions, making it valuable in medicinal chemistry for constructing carbon-carbon bonds. Commonly employed in the preparation of protease inhibitors and anticancer agents. The presence of both amino and fluoro groups allows for further functionalization and improved binding selectivity in drug design. Also utilized in the creation of boron-containing compounds for potential use in neutron capture therapy and molecular imaging.